Optiver Holding B.V. Regeneron Pharmaceuticals, Inc. Transaction History

Optiver Holding B.V.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$902.69 - $993.35 $193,175 - $212,576	214 New	214 $205,000
Q4 2022 Feb 10, 2023	BUY	$705.89 - $766.39 $2,117 - $2,299	3 New	3 $2,000
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $64,868 - $76,128	-109 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $48,218 - $57,200	84 Added 336.0%	109 $66,000
Q2 2021 Aug 16, 2021	SELL	$472.8 - $558.54 $1.37 Million - $1.62 Million	-2,893 Reduced 99.14%	25 $14,000
Q1 2021 May 14, 2021	BUY	$446.73 - $548.2 $1.3 Million - $1.6 Million	2,918 New	2,918 $1.38 Million

1,529

82.7M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $74.7B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Optiver Holding B.V., based on Form 13F filings with the SEC.

Stay updated on Optiver Holding B.V. with notifications on news.